Table 3.
Varicella and measles vaccination coverage, by region and survey year
| Survey 2009 | Survey 2010 | Survey 2011 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | n (%) | p-valuea | N | n (%) | p-valuea | N | n (%) | p-valuea | ||
| Vaccinated against varicellabat time of survey, first dose; n (%) | Munich | 314 | 165 (52.5) | <0.001*** | 288 | 194 (67.4) | <0.001*** | 283 | 196 (69.3) | <0.001*** |
| Würzburg | 340 | 246 (72.4) | 350 | 283 (80.9) | 329 | 273 (83.0) | ||||
| Varicella vaccination recommended by physicianb | Munich | 304 | 183 (60.2) | <0.001*** | 282 | 188 (66.7) | <0.001*** | 282 | 207 (73.4) | <0.001*** |
| Würzburg | 335 | 255 (76.1) | 346 | 285 (82.4) | 328 | 280 (85.4) | ||||
| Vaccinated against measles at time of survey, first dose; n (%) | Munich | 328 | 289 (88.1) | 0.162 | 301 | 269 (89.4) | 0.094 | 302 | 275 (91.1) | 0.039* |
| Würzburg | 354 | 324 (91.5) | 368 | 343 (93.2) | 343 | 327 (95.3) | ||||
aPearson’s Chi2 test
bonly children susceptible for varicella at 11 months of age
***: significant at 0.1% level, *: significant at 5% level